Fritextsökning
Innehållstyper
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Billigare och tidigare upptäckt av cancer
Tjugo biomarkörer i stället för en. Ett blod- eller urinprov i stället för biopsi eller röntgen. Och AI som bedömer. Så ska Elypta möjliggöra tidigare diagnostik av cancer.
-
New Nordic biotech company
The Swiss biotech company Tillots Pharma opens a office in Stockholm, which will be run under private management.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Analytisk kemi nytt ben för Recipharm
CDMO Recipharm lanserar en fristående tjänst inom analytisk kemi.
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Oro att coronaviruset smittar mellan djur och människor
Forskare vill se studier som klargör om djur smittade med sars-cov-2 kan smitta människor.
-
Diagnostics for personalized medicine
Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Digitalisering och kliniska prövningar
Effektivare kliniska prövningar och ny teknologi för dokumentation av behandlingar - Digitaliseringen öppnar många möjligheter. Ola Björkman rapporterar från BIO i San Diego.
-
Lucka 23 - vem finns här?
Varje dag fram till jul får vi här veta vad profiler i life science-världen har på sin önskelista.
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Ny design på klinstudie
I ett samarbete mellan FDA, NIH och läkemedelsindustrin utvärderas ett flertal behandlingar i samma studie.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Hey there Summer Eriksson......
.....biomedical analysist at Akademsika sjukhuset in Uppsala. Why are you here at Biotech Forum and Scanlab?
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Tekniska framsteg i fokus
På det årliga internationella forumet New Horizons in Biologics & Bioprocessing den 17 december på Stockholm Waterfront samlas branschen för att höra om det sen...
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Ny vd när Medivir går in i ny fas
I samband med att Medivir genomfört en omorganisation av sin verksamhet kliver Christine Lind in som vd för bolaget.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Microwave reactor for use in various synthesis applications
The Monowave 300 microwave reactor offers 850 watts of power for a variety of synthesis applications.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Iddo Leshem tar sig an Norden
Iddo Leshem har börjat sin nya roll som general manager för Bristol-Myers Squibb Norden.